EU Industry Decries Price Cuts And Clawbacks
Report Demonstrates Need For Pricing And Reimbursement Reform
A detailed report published by Medicines for Europe setting out policies affecting the off-patent industry across 22 European countries demonstrates the urgent need for pricing and reimbursement and procurement reforms, the association insists.
